P D Robbins|C H Evans|Y Chernajovsky - JoVE Visualize

Showing results (401-410 of 522) with videos related to

Pageof 53

Sort By:

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 1, 1997

Nitric oxide and proteoglycan turnover in rabbit articular cartilageM Stefanovic-Racic, M O Möllers, L A Miller, et al.

International Journal of Cancer|September 15, 1980

Plasminogen activator synthesis accompanying chemical carcinogen-induced in vitro transformation of Syrian hamster and guinea-pig fetal cellsE E Sisskin, I B Weinstein, C H Evans, et al.

Gene Therapy|July 2, 2004

Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoyJ Machen, S Bertera, Y Chang, et al.

Gene Therapy|September 7, 1999

Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipientsL Lu, A Gambotto, W C Lee, et al.

Gene Therapy|September 1, 1996

Analysis of the relative level of gene expression from different retroviral vectors used for gene therapyJ Byun, S H Kim, J M Kim, et al.

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1995

Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markersB R Dix, P D Robbins, D V Spagnolo, et al.

Annals of the Rheumatic Diseases|April 30, 2005

Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in miceP Mukherjee, S-Y Yang, B Wu, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999

Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyW Hashimoto, T Osaki, H Okamura, et al.

Gene Therapy|September 1, 1995

Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transferG M Mueller, L R McKenzie, G E Homanics, et al.

The Journal of Surgical Research|February 1, 1995

Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapyI Pappo, H Tahara, P D Robbins, et al.

Pageof 53

Showing results (401-410 of 522) with videos related to

Sort By:

Pageof 53

Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 1, 1997

Nitric oxide and proteoglycan turnover in rabbit articular cartilageM Stefanovic-Racic, M O Möllers, L A Miller, et al.

International Journal of Cancer|September 15, 1980

Plasminogen activator synthesis accompanying chemical carcinogen-induced in vitro transformation of Syrian hamster and guinea-pig fetal cellsE E Sisskin, I B Weinstein, C H Evans, et al.

Gene Therapy|July 2, 2004

Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoyJ Machen, S Bertera, Y Chang, et al.

Gene Therapy|September 7, 1999

Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipientsL Lu, A Gambotto, W C Lee, et al.

Gene Therapy|September 1, 1996

Analysis of the relative level of gene expression from different retroviral vectors used for gene therapyJ Byun, S H Kim, J M Kim, et al.

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1995

Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markersB R Dix, P D Robbins, D V Spagnolo, et al.

Annals of the Rheumatic Diseases|April 30, 2005

Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in miceP Mukherjee, S-Y Yang, B Wu, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999

Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyW Hashimoto, T Osaki, H Okamura, et al.

Gene Therapy|September 1, 1995

Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transferG M Mueller, L R McKenzie, G E Homanics, et al.

The Journal of Surgical Research|February 1, 1995

Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapyI Pappo, H Tahara, P D Robbins, et al.

Pageof 53